| Literature DB >> 34066652 |
Raybel Muñoz1, Eva M Santos1, Carlos A Galan-Vidal1, Jose M Miranda2, Aroa Lopez-Santamarina2, Jose A Rodriguez1.
Abstract
Ternary quantum dots (QDs) are novel nanomaterials that can be used in chemical analysis due their unique physicochemical and spectroscopic properties. These properties are size-dependent and can be adjusted in the synthetic protocol modifying the reaction medium, time, source of heat, and the ligand used for stabilization. In the last decade, several spectroscopic methods have been developed for the analysis of organic and inorganic analytes in biological, drug, environmental, and food samples, in which different sensing schemes have been applied using ternary quantum dots. This review addresses the different synthetic approaches of ternary quantum dots, the sensing mechanisms involved in the analyte detection, and the predominant areas in which these nanomaterials are used.Entities:
Keywords: FRET; PET; analytical methodologies; enhancement; ternary QDs
Year: 2021 PMID: 34066652 PMCID: PMC8125818 DOI: 10.3390/molecules26092764
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Methods for QD synthesis.
Figure 2General procedure for synthesis of QDs by top-down techniques.
Figure 3Synthesis of QDs by vapor phase methods.
Figure 4Synthesis of QDs by aqueous methods.
Hydrothermal synthesis conditions and spectroscopic parameters of ternary QDs.
| Quantum Dots | Synthesis Strategy | Temperature-Time | Size (nm) | QY (%) | λem Max (nm) | Ref |
|---|---|---|---|---|---|---|
| CuInS2/ZnS | Reflux | 95 °C | 3.04 ± 0.47 | 12.3 | 708 | [ |
| CuInS2/ZnS | Reflux | 100 °C | 1.8 ± 0.4 | - | 500–680 | [ |
| AgInS2/ZnS | Reflux | 95 °C | 2.9 | 49.5 | 623 | [ |
| CuInS2 | Solvothermal | 150 °C | - | 19.6 | ≈400 | [ |
| CuInSe2/ZnS | Reflux | 100 °C | 4.19 (mean) | 17.2 | 535 | [ |
| CuInS2/ZnS | Microwave | 95 °C | 8.3 | 20.4 | 570 | [ |
| AgInS2 | Hot injection method | 90 °C | 3–8 | - | 626 | [ |
| AgInS2 | Reflux | 95 °C | 2.5 | 10.3 | 680 | [ |
| AgInS2/ZnS | Microwave | 90 °C | 2.7 | 60 | 625 | [ |
Figure 5PET mechanisms of QDs as donor and acceptor (VB: valence band, CB: conduction band, e−: electron, h+: hole).
Figure 6FRET mechanism of QDs and an acceptor (VB: valence band, CB: conduction band, e−: electron, h+: hole).
Figure 7Resulting enhancing of QDs due to the passivation of traps (VB: valence band, CB: conduction band).
Analytical methodologies employing ternary QDs.
| Analyte | Ternary QDs | Sample | Interaction Mechanism | LOD | Ref | |
|---|---|---|---|---|---|---|
| Food | Folic acid | AgInS2/ZnS | Fruit juices | Inhibition of fluorescence due to an antigen-antibody interaction (Immunoassay) | 0.1 ng mL−1 | [ |
| Glutathione | CuInS2 | Tomatoes and urine | Recovery of the fluorescence quenched | 73 nM | [ | |
| Melatonin | AgInS2 | Dietary supplements | Chemiluminescence | 0.44 mg L−1 | [ | |
| Glufosinate | CuInS2 | Tea leaves | Recovery of the fluorescence quenched | 0.01 mg L−1 | [ | |
| Environmental | Diniconazole | CuInS2 | Tap water | Chemiluminescence | 1 nM | [ |
| Zn2+ | CuInS2 | Tap water | Recovery of the fluorescence quenched | 4.5 μM | [ | |
| 2,4,6-Trinitrophenol | CuInS2 | Tap, spring, and waste water | Quenching of fluorescence | 28 nM | [ | |
| Cu2+ | CuInS2 | Tap and pond water | Cu2+: Quenching | Cu2+: 0.037 mM | [ | |
| Pharmaceutical | Ascorbic acid | CuInS2 | Vitamin C tablets | Enhancement | 0.05 mM | [ |
| Ciprofloxacin | AgInS2 | Pharmaceutical tablets | Quenching | 0.12 μg mL−1 | [ | |
| Sparfloxacin | CuInS2 | Pharmaceutical tablets | Quenching | 0.5 μg mL−1 | [ | |
| Atenolol | AgInS2/ZnS | Pharmaceutical formulations | FRET | 1.05 mg L−1 | [ | |
| Biological | Doxorubicin hydrochloride | CuInSe2/ZnS | Human serum | Quenching due to surface plasmon resonance effect | 0.05 µM | [ |
| Adenosine-5′-triphosphate | CuInS2 | Human serum | Enhancement | 3 μM | [ | |
| Heparin | CuInS2 | Fetal bovine serum | Recovery of the fluorescence quenched | 12.46 nM | [ | |
| Histidine (His) | CuInS2 | Human serum | Recovery of the fluorescence quenched | His: 0.7 mM | [ | |
| Dopamine | CuInS2 | Human serum | Quenching | 0.2 µM | [ | |
| Uric acid | CuInS2/ZnS | Human serum and urine | Enzymatic method, quenching | 50 nM | [ |